| Literature DB >> 34072500 |
Abanoub Riad1,2,3, Huthaifa Abdulqader2, Mariana Morgado2,4, Silvi Domnori2, Michal Koščík1, José João Mendes4, Miloslav Klugar1,3, Elham Kateeb5,6, On Behalf Of Iads-Score.
Abstract
BACKGROUND: Acceleration of mass vaccination strategies is the only pathway to overcome the COVID-19 pandemic. Healthcare professionals and students have a key role in shaping public opinion about vaccines. This study aimed to evaluate the attitudes of dental students globally towards COVID-19 vaccines and explore the potential drivers for students' acceptance levels.Entities:
Keywords: COVID-19 vaccines; cross-sectional studies; decision making; dental education; dental students; international association of dental students; mass vaccination; multicentre study; social determinants of health
Year: 2021 PMID: 34072500 PMCID: PMC8226539 DOI: 10.3390/vaccines9060566
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
The results of the test re-test reliability 1.
| Participant | Participant | ||
|---|---|---|---|
| No. 1 | 0.8 | No. 10 | 0.6 |
| No. 2 | 0.8 | No. 11 | 1.0 |
| No. 3 | 0.9 | No. 12 | 0.7 |
| No. 4 | 1.0 | No. 13 | 1.0 |
| No. 5 | 1.0 | No. 14 | 0.8 |
| No. 6 | 0.6 | No. 15 | 0.7 |
| No. 7 | 0.6 | No. 16 | 1.0 |
| No. 8 | 1.0 | No. 17 | 0.8 |
| No. 9 | 0.6 | No. 18 | 0.8 |
1 Cohen’s Kappa statistic (κ): 0.01–0.2 as none to slight, 0.21–0.4 as fair, 0.41–0.6 as moderate, 0.61–0.80 as substantial, and 0.81–1.0 as perfect agreement [32].
Demographic characteristics of the participating dental students worldwide, February 2021.
| Variable | Outcome | Frequency | Percentage | Cumulative Percentage |
|---|---|---|---|---|
| Gender | Female | 4682 | 70.5% | 70.5% |
| Male | 1836 | 27.7% | 98.2% | |
| Non-binary | 53 | 0.8% | 99% | |
| Prefer not to say | 68 | 1% | 100% | |
| Age | 17–22 years | 4218 | 63.5% | 63.5% |
| 23–40 years | 2421 | 36.5% | 100% | |
| Academic Level | 1st Year | 979 | 14.7% | 14.7% |
| 2nd Year | 1227 | 18.5% | 33.2% | |
| 3rd Year | 1422 | 21.4% | 54.6% | |
| 4th Year | 1259 | 19% | 73.6% | |
| 5th Year | 817 | 12.3% | 85.9% | |
| 6th Year | 240 | 3.6% | 89.5% | |
| Internship | 322 | 4.9% | 94.4% | |
| Fresh Graduate | 373 | 5.6% | 100% | |
| Country | Albania | 57 | 0.9% | 0.9% |
| Canada | 183 | 2.8% | 3.6% | |
| Croatia | 169 | 2.5% | 6.2% | |
| Ecuador | 381 | 5.7% | 11.9% | |
| Estonia | 78 | 1.2% | 13.1% | |
| Indonesia | 416 | 6.3% | 19.3% | |
| Iran | 388 | 5.8% | 25.2% | |
| Iraq | 354 | 5.3% | 30.5% | |
| Italy | 492 | 7.4% | 37.9% | |
| Latvia | 129 | 1.9% | 39.9% | |
| Lebanon | 107 | 1.6% | 41.5% | |
| Lithuania | 291 | 4.4% | 45.9% | |
| Malaysia | 350 | 5.3% | 51.1% | |
| Nepal | 153 | 2.3% | 53.4% | |
| Pakistan | 379 | 5.7% | 59.2% | |
| Palestine | 417 | 6.3% | 65.4% | |
| Portugal | 389 | 5.9% | 71.3% | |
| Russia | 596 | 9.0% | 80.3% | |
| Sudan | 467 | 7.0% | 87.3% | |
| Tunisia | 283 | 4.3% | 91.6% | |
| Turkey | 386 | 5.8% | 97.4% | |
| USA | 174 | 2.6% | 100% | |
| Geographic Region | Africa | 750 | 11.3% | 11.3% |
| Americas | 738 | 11.1% | 22.4% | |
| Asia-Pacific | 1298 | 19.6% | 41.9% | |
| Eastern Mediterranean | 1266 | 19.1% | 61% | |
| Europe | 2587 | 39% | 100% | |
| Economic Level | Low-income Economy | 467 | 7% | 7% |
| Lower-middle-income Economy | 1232 | 18.6% | 25.6% | |
| Upper-middle-income Economy | 3035 | 45.7% | 71.3% | |
| High-income Economy | 1905 | 28.7% | 100% |
COVID-19-related experience of the dental students stratified by economic level, February 2021.
| Variable | LLMI | UMHI | Total | Sig. 1 |
|---|---|---|---|---|
| I had been infected by SARS-CoV-2 | 332 (19.5%) | 773 (15.6%) | 1105 (16.6%) | <0.01 |
| I had been caring for someone with COVID-19 infection | 538 (31.7%) | 1270 (25.7%) | 1808 (27.2%) | <0.01 |
| I know someone who had COVID-19 infection | 1515 (89.2%) | 4286 (86.8%) | 5801 (87.4%) | 0.01 |
| I know someone who had died from COVID-19 infection | 945 (55.6%) | 2086 (42.2%) | 3031 (45.7%) | <0.01 |
1 Chi-squared test was used with a significance level ≤0.05.
Dental students’ attitudes towards the COVID-19 vaccine stratified by economic level, February 2021.
| Variable | Outcome | LLMI | UMHI | Total | Sig. 1 |
|---|---|---|---|---|---|
| I am willing to take the COVID-19 | Totally Disagree = 1 | 150 (8.8%) | 341 (6.9%) | 491 (7.4%) | 0.01 |
| Disagree = 2 | 126 (7.4%) | 308 (6.2%) | 434 (6.5%) | 0.09 | |
| Not Sure = 3 | 517 (30.4%) | 977 (19.8%) | 1494 (22.5%) | <0.01 | |
| Agree = 4 | 441 (26%) | 1054 (21.3%) | 1495 (22.5%) | <0.01 | |
| Totally Agree = 5 | 465 (27.4%) | 2260 (45.7%) | 2725 (41%) | <0.01 | |
| Total (1–5) | 3.56 ± 1.21 | 3.93 ± 1.23 | 3.83 ± 1.24 | <0.01 |
1 Chi-squared and Mann–Whitney U-test were used with a significance level ≤0.05.
Dental students’ vaccine-related attitude drivers stratified by economic level, February 2021.
| Variable | Outcome | LLMI | UMHI | Total | Sig. 1 |
|---|---|---|---|---|---|
| Contextual Drivers | |||||
| Do reports you hear/read in the media/on social media make you re-consider the choice to take the COVID-19 vaccine? | Yes = 2 | 713 (42%) | 1504 (30.4%) | 2217 (33.4%) | |
| Not Sure = 1 | 464 (27.3%) | 1055 (21.4%) | 1519 (22.9%) | ||
| No = 0 | 522 (30.7%) | 2381 (48.2%) | 2903 (43.7%) | ||
| Total (0–2) | 1.11 ± 0.85 | 0.82 ± 0.87 | 0.9 ± 0.87 | <0.01 | |
| Do celebrities, religious or political leaders | Yes = 2 | 362 (21.3%) | 716 (14.5%) | 1078 (16.2%) | |
| Not Sure = 1 | 227 (13.4%) | 600 (21.1%) | 827 (12.5%) | ||
| No = 0 | 1110 (65.3%) | 3624 (73.4%) | 4734 (71.3%) | ||
| Total (0–2) | 0.56 ± 0.82 | 0.41 ± 0.73 | 0.45 ± 0.76 | <0.01 | |
| Do you trust that your government is making | Yes = 2 | 460 (27.1%) | 1871 (37.9%) | 2331 (35.1%) | |
| Not Sure = 1 | 550 (32.4%) | 1580 (32%) | 2130 (32.1%) | ||
| No = 0 | 689 (40.6%) | 1489 (30.1%) | 2178 (32.8%) | ||
| Total (0–2) | 0.87 ± 0.81 | 1.08 ± 0.82 | 1.02 ± 0.82 | <0.01 | |
| Do you trust pharmaceutical companies to | Yes = 2 | 629 (37%) | 2521 (51%) | 3150 (47.4%) | |
| Not Sure = 1 | 579 (34.1%) | 1462 (29.6%) | 2041 (30.7%) | ||
| No = 0 | 491 (28.9%) | 957 (19.4%) | 1448 (21.8%) | ||
| Total (0–2) | 1.08 ± 0.81 | 1.32 ± 0.78 | 1.26 ± 0.79 | <0.01 | |
| Do you know anyone who will not take the vaccine because of religious or cultural values? | Yes = 2 | 289 (17%) | 1234 (25%) | 1523 (22.9%) | |
| Not Sure = 1 | 181 (10.7%) | 649 (13.1%) | 830 (12.5%) | ||
| No = 0 | 1229 (72.3%) | 3057 (61.9%) | 4286 (64.6%) | ||
| Total (0–2) | 0.45 ± 0.77 | 0.63 ± 0.86 | 0.58 ± 0.84 | <0.01 | |
| If “Yes”, do you agree with these people? | Yes = 2 | 52 (18%) | 135 (10.9%) | 187 (12.3%) | |
| Not Sure = 1 | 30 (10.4%) | 162 (13.1%) | 192 (12.6%) | ||
| No = 0 | 207 (71.6%) | 937 (75.9%) | 1144 (75.1%) | ||
| Total (0–2) | 0.46 ± 0.78 | 0.35 ± 0.67 | 0.37 ± 0.69 | <0.01 | |
| Individual/Group Drivers | |||||
| Do you think that there are better ways to prevent COVID-19 than using vaccines (e.g., developing immunity by becoming sick and recovering)? | Yes = 2 | 647 (38.1%) | 1109 (22.4%) | 1756 (26.4%) | |
| Not Sure = 1 | 432 (25.4%) | 1523 (30.8%) | 1955 (29.4%) | ||
| No = 0 | 620 (36.5%) | 2308 (46.7%) | 2928 (44.1%) | ||
| Total (0–2) | 1.02 ± 0.86 | 0.76 ± 0.8 | 0.82 ± 0.82 | <0.01 | |
| Do you feel you have enough information about COVID-19 vaccines and their safety? | Yes = 2 | 458 (27%) | 1633 (33.1%) | 2091 (31.5%) | |
| Not Sure = 1 | 399 (23.5%) | 1439 (29.1%) | 1838 (27.7%) | ||
| No = 0 | 842 (49.6%) | 1868 (37.8%) | 2710 (40.8%) | ||
| Total (0–2) | 0.77 ± 0.85 | 0.95 ± 0.84 | 0.91 ± 0.845 | <0.01 | |
| Vaccine-specific Drivers | |||||
| Do you think that the benefits of COVID-19 | Yes = 2 | 683 (40.2%) | 2686 (54.4%) | 3369 (50.7%) | |
| Not Sure = 1 | 661 (38.9%) | 1421 (28.8%) | 2082 (31.4%) | ||
| No = 0 | 355 (20.9%) | 833 (16.9%) | 1188 (17.9%) | ||
| Total (0–2) | 1.19 ± 0.76 | 1.38 ± 0.76 | 1.33 ± 0.76 | <0.01 | |
| In general, when a new vaccine is introduced, | Yes = 2 | 638 (37.6%) | 2233 (45.2%) | 2871 (43.2%) | |
| Not Sure = 1 | 556 (32.7%) | 1606 (32.5%) | 2162 (32.6%) | ||
| No = 0 | 505 (29.7%) | 1101 (22.3%) | 1606 (24.2%) | ||
| Total (0–2) | 1.08 ± 0.82 | 1.23 ± 0.79 | 1.19 ± 0.8 | <0.01 | |
| Do you feel confident that the health centre or doctor’s office will have the COVID-19 vaccines you need, when you need them? | Yes = 2 | 571 (33.6%) | 2132 (43.2%) | 2703 (40.7%) | |
| Not Sure = 1 | 617 (36.3%) | 1541 (31.2%) | 2158 (32.5%) | ||
| No = 0 | 511 (30.1%) | 1267 (25.6%) | 1778 (26.8%) | ||
| Total (0–2) | 1.04 ± 0.8 | 1.18 ± 0.81 | 1.14 ± 0.81 | <0.01 | |
1 Mann–Whitney U-test was used with a significance level ≤0.05.
Dental students’ demographic determinants of COVID-19 acceptance, February 2021.
| Variable | Outcome | Acceptance Level | Sig. 1 |
|---|---|---|---|
| Gender | Female | 3.83 ± 1.23 | 0.01 |
| Male | 3.87 ± 1.26 | ||
| Non-binary | 3.47 ± 1.42 | ||
| Prefer not to say | 3.44 ± 1.43 | ||
| Academic Level | 1st Year | 3.73 ± 1.28 | 0.11 |
| 2nd Year | 3.81 ± 1.19 | ||
| 3rd Year | 3.91 ± 1.19 | ||
| 4th Year | 3.90 ± 1.25 | ||
| 5th Year | 3.93 ± 1.25 | ||
| 6th Year | 3.80 ± 1.31 | ||
| Internship | 3.59 ± 1.26 | ||
| Fresh Graduate | 3.66 ± 1.26 | ||
| Clinical Training | Preclinical (1st year and 2nd year) | 3.77 ± 1.32 | 0.01 |
| Clinical (3rd year–Graduate) | 3.86 ± 1.24 | ||
| Country | Albania | 3.14 ± 1.27 | <0.01 |
| Canada | 4.41 ± 1 | ||
| Croatia | 3.73 ± 1.26 | ||
| Ecuador | 3.86 ± 1.19 | ||
| Estonia | 3.62 ± 1.22 | ||
| Indonesia | 4.37 ± 0.89 | ||
| Iran | 3.38 ± 1.38 | ||
| Iraq | 3.27 ± 1.17 | ||
| Italy | 4.7 ± 0.8 | ||
| Latvia | 3.8 ± 1.37 | ||
| Lebanon | 3.86 ± 1.18 | ||
| Lithuania | 4.18 ± 1.12 | ||
| Malaysia | 4.33 ± 0.91 | ||
| Nepal | 3.91 ± 1.04 | ||
| Pakistan | 3.97 ± 1.01 | ||
| Palestine | 3.72 ± 1.27 | ||
| Portugal | 4.57 ± 0.85 | ||
| Russia | 2.85 ±1.12 | ||
| Sudan | 3.37 ± 1.17 | ||
| Tunisia | 2.88 ± 1.2 | ||
| Turkey | 3.99 ± 1.11 | ||
| USA | 4.53 ± 1.04 | ||
| Geographic Region | Africa | 3.18 ± 1.2 | <0.01 |
| Americas | 4.15 ± 1.15 | ||
| Asia-Pacific | 4.19 ± 1 | ||
| Eastern Mediterranean | 3.5 ± 1.29 | ||
| Europe | 3.91 ± 1.26 | ||
| Economic Level | Low-income Economy | 3.37 ± 1.17 | <0.01 |
| Lower-middle-income Economy | 3.63 ± 1.23 | ||
| Upper-middle-income Economy | 3.66 ± 1.25 | ||
| High-income Economy | 4.36 ± 1.07 |
1 Mann–Whitney U and Kruskal–Wallis tests were used with a significance level ≤0.05.
Figure 1Dental students’ COVID-19 vaccine acceptance level by state, February 2021.
Figure 2Dental students’ COVID-19 vaccine acceptance by (a) economic level and (b) geographic region, February 2021.
Dental students’ COVID-19 vaccine acceptance and COVID-19-related experience, February 2021.
| Variable | No | Yes | Sig. 1 |
|---|---|---|---|
| I had been infected by SARS-CoV-2 | 3.88 ± 1.21 | 3.57 ± 1.36 | <0.01 |
| I had been caring for someone with COVID-19 infection | 3.89 ± 1.21 | 3.68 ± 1.31 | <0.01 |
| I know someone who had COVID-19 infection | 3.68 ± 1.25 | 3.86 ±1.24 | <0.01 |
| I know someone who had died from COVID-19 infection | 3.89 ± 1.22 | 3.77 ± 1.26 | <0.01 |
1 Mann–Whitney U-test was used with a significance level ≤0.05.
Drivers of dental students’ COVID-19 vaccine acceptance worldwide, February 2021.
| Category | Driver | No | Yes | Sig. 1 |
|---|---|---|---|---|
| Contextual | Media | 3.99 ± 1.31 | 3.71 ± 1.21 | <0.01 |
| Public Figures | 3.87 ± 1.25 | 3.82 ± 1.27 | 0.24 | |
| Government | 3.37 ± 1.30 | 4.29 ± 1.10 | <0.01 | |
| Pharmaceuticals | 3.06 ± 1.30 | 4.31 ± 1.06 | <0.01 | |
| Values | 4.30 ± 1.05 | 2.75 ± 1.44 | <0.01 | |
| Individual/Group | Natural Immunity | 4.16 ± 1.11 | 3.35 ± 1.38 | <0.01 |
| Sufficient Knowledge | 3.48 ± 1.19 | 4.21 ± 1.23 | <0.01 | |
| Vaccine-specific | Risk/Benefit Ratio | 3.14 ± 1.37 | 4.31 ± 1.06 | <0.01 |
| New Vaccine | 3.06 ± 1.28 | 4.37 ± 1.03 | <0.01 | |
| Availability | 3.44 ± 1.3 | 4.17 ± 1.15 | <0.01 |
1 Mann–Whitney U-test was used with a significance level ≤0.05.